Welcome to LookChem.com Sign In|Join Free
  • or
2,6-Dichloro-3-phenylquinoxaline is a chemical compound characterized by the molecular formula C12H6Cl2N2. It is a yellow crystalline substance known for its potential applications in the synthesis of pharmaceuticals and agrochemicals. 2,6-Dichloro-3-phenylquinoxaline also exhibits notable biological activities, such as antibacterial, antifungal, and anti-inflammatory properties, which have spurred interest in its development as a therapeutic agent for various diseases. However, further research is needed to assess its toxicological profile and environmental impact to ensure its safe and sustainable application.

76672-25-8

Post Buying Request

76672-25-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

76672-25-8 Usage

Uses

Used in Pharmaceutical Synthesis:
2,6-Dichloro-3-phenylquinoxaline is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical structure allows for the development of new drugs with potential therapeutic benefits.
Used in Agrochemical Synthesis:
In the agrochemical industry, 2,6-Dichloro-3-phenylquinoxaline is utilized as a precursor for the production of pesticides and other agrochemicals. Its incorporation into these products can enhance their effectiveness in controlling pests and diseases in agriculture.
Used in Antibacterial Applications:
2,6-Dichloro-3-phenylquinoxaline is used as an antibacterial agent due to its ability to inhibit the growth of certain bacteria. This property makes it a potential candidate for the development of new antibiotics to combat bacterial infections.
Used in Antifungal Applications:
2,6-Dichloro-3-phenylquinoxaline is also used as an antifungal agent, demonstrating its potential to treat fungal infections by inhibiting the growth of fungi.
Used in Anti-inflammatory Applications:
2,6-Dichloro-3-phenylquinoxaline exhibits anti-inflammatory properties, making it a candidate for the development of new therapeutic agents to treat inflammatory conditions.
Used in Therapeutic Agent Development:
Owing to its diverse biological activities, 2,6-Dichloro-3-phenylquinoxaline is being studied for its potential use in the development of new therapeutic agents for the treatment of various diseases, pending further investigation into its safety and efficacy.

Check Digit Verification of cas no

The CAS Registry Mumber 76672-25-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,6,7 and 2 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 76672-25:
(7*7)+(6*6)+(5*6)+(4*7)+(3*2)+(2*2)+(1*5)=158
158 % 10 = 8
So 76672-25-8 is a valid CAS Registry Number.

76672-25-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-dichloro-3-phenylquinoxaline

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:76672-25-8 SDS

76672-25-8Relevant academic research and scientific papers

Quinoxaline chemistry. Part 6. Synthesis and evaluation of antiulcer and gastroprotective activity of 2-[arylmethylmercapto-,arylmethylsulfinyl-,piperazinyl-3-R-substituted ]quinoxalines

Piras,Loriga,Paglietti,Demontis,Varoni,Fattaccio,Anania

, p. 569 - 577 (2007/10/03)

Thirty compounds possessing quinoxaline structure bearing either substituted arylmethylmercapto-, arylmethylsulfinyl group or a piperazinyl moiety in position 2 were prepared in order to evaluate an antiulcer and gastroprotective activity in rat pylorus ligature, in comparison with omeprazole and ranitidine at the dose of 100 mg/kg after oral administration. Among the compounds of the first group one third showed a moderate activity being about half potent as omeprazole whereas in the second group compound 5b exhibited an activity superior to that of ranitidine accompanied with the lowest incidence of lesions and mortality and another compound (5i) was equiactive as ranitidine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 76672-25-8